Grifols SA (ADR) - Level III Live Stock Price Today, Share Analysis and Chart

Name: Grifols SA - ADR - Level III: Is Infosys Ltd. worth buying?
Item: Grifols SA - ADR - Level III
Rating: 1.947402875
Author: Trendlyne DVM scores

Value Trap

about

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products d...

7.36 0.05 (0.68%)

28.05% Fall from 52W High

356.7K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Affordable Valuation

65.7 / 100

Technically Bearish

34.6 / 100

Value Trap These stocks have weak financials and momentum. Buying interest is low, investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 48%

2 analysts

Grifols SA (ADR) - Level III Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..